Many CML patients today are living with side effects so strong that their quality of life is greatly reduced, according to a survey by the CML Society of Canada.
Twenty-five years after the discovery of HIV, Canadians living with the illness carry a huge stigma and social isolation, according to recent research findings.
Canadian evidence-based guidelines support the use of a cholinesterase inhibitor or memantine, or both drugs for the management of patients with severe Alzheimer's disease.